sepsi
older
adult
mani
challeng
affect
rate
septic
diagnosi
treatment
monitor
paramet
numer
agerel
chang
comorbid
contribut
increas
risk
infect
older
adult
also
atyp
symptomatolog
delay
diagnosi
due
variou
pharmacokineticpharmacodynam
chang
older
adult
medic
absorb
metabol
elimin
differ
rate
compar
younger
adult
increas
risk
advers
drug
reaction
due
use
drug
therapi
need
sepsi
manag
review
provid
inform
aid
diagnosi
well
offer
recommend
monitor
treat
sepsi
older
adult
popul
older
adult
increas
risk
contract
infecti
pathogen
due
declin
immun
system
addit
agerel
chang
throughout
bodi
system
due
vulner
older
adult
increas
risk
sepsi
often
diagnosi
initi
sepsi
bundl
delay
due
abnorm
infecti
diseas
present
older
adult
recent
surviv
sepsi
campaign
ssc
guidelin
recommend
initi
antibiot
fluid
resuscit
vasopressor
howev
recommend
specif
design
older
adult
treatment
septic
shock
syndrom
limit
literatur
exist
guid
appropri
select
dose
pharmacotherapi
older
adult
mani
clinic
trial
adult
patient
sever
sepsi
septic
shock
includ
larg
proport
older
adult
rang
anywher
studi
popul
enrol
patient
averag
age
year
suggest
result
could
applic
older
adult
popul
howev
pauciti
publish
data
evalu
effect
vasoact
therapi
overal
outcom
specif
patient
advanc
age
abl
make
practic
recommend
select
specif
vasopressor
inotrop
medic
larg
guid
expert
opinion
clinician
prefer
individu
hemodynam
paramet
minim
advers
effect
tachycardia
newonset
arrhythmia
older
adult
popul
continu
grow
treat
sepsi
becom
costli
endeavor
hospit
cost
current
exceed
billion
dollar
per
year
mani
challeng
treat
diagnos
older
adult
sepsi
addit
inabl
older
adult
combat
infecti
pathogen
purpos
expert
review
identifi
agerel
chang
increas
risk
sepsi
caus
difficulti
diagnosi
provid
recommend
treat
sepsi
older
adult
immunosenesc
agerel
chang
immun
system
otherwis
known
immunosenesc
increas
vulner
older
adult
contract
infect
decreas
older
adult
immun
respons
multipl
complex
factor
contribut
immunosenesc
increas
risk
older
adult
acquir
sepsi
tabl
includ
addit
factor
may
contribut
predispos
factor
sepsi
older
adult
overal
decreas
cell
count
marker
immunosenesc
thymal
involut
occur
older
adult
age
lead
decreas
thymal
mass
also
decreas
output
cell
factor
decreas
number
cell
caus
decreas
activ
secret
prolifer
effect
activ
lymphocyt
activ
lymphocyt
delay
blunt
challeng
immun
system
erad
invad
pathogen
addit
factor
immunosenesc
decreas
number
b
cell
reduc
product
antibodi
antigenexperienc
b
cell
overproduc
due
respons
presenc
environment
autoantigen
wherea
follicular
bcell
product
diminish
older
adult
higher
risk
contract
infecti
caus
invas
pathogen
pathogen
includ
listeria
monocytogen
west
nile
viru
sever
acut
respiratori
syndrom
viru
decreas
amount
b
cell
unabl
cope
respond
new
antigen
helper
cell
mostli
absent
older
adult
due
lack
express
costimul
molecul
need
interact
cell
activ
b
cell
part
humor
adapt
immun
due
impair
helper
cell
decreas
amount
b
cell
immun
system
unabl
mount
respons
newer
antigen
includ
vaccin
anoth
factor
older
adult
appear
chronic
lowgrad
proinflammatori
state
debat
one
major
caus
proinflammatori
statewheth
sole
due
atherosclerosi
reactiv
viral
ill
older
adult
increas
concentr
tumor
necrosi
factor
alpha
tnfalpha
creactiv
protein
crp
inflammatori
factor
circul
bloodstream
may
blunt
delay
overal
immun
respons
downregul
receptor
new
term
inflammag
introduc
describ
chronic
lowgrad
inflamm
occur
older
adult
addit
crp
older
adult
also
increas
level
interleukin
especi
sever
sepsi
older
adult
exhibit
larger
ratio
compar
tnf
associ
increas
mortal
addit
agerel
chang
system
may
increas
older
adult
risk
infect
within
respiratori
system
decreas
reserv
lung
capac
reduc
cough
reflex
clear
bacteria
expector
reduc
respiratori
muscl
endur
older
adult
experi
decreas
circul
thyroid
hormon
level
decreas
thyroid
hormon
level
link
decreas
natur
killer
cell
activ
provid
addit
rational
blunt
immun
respons
novel
antigen
factor
affect
immunosenesc
older
adult
elev
risk
infect
diagnosi
sepsi
older
adult
especi
difficult
often
goe
underdiagnos
older
adult
sepsi
often
present
atyp
nonspecif
symptom
common
exampl
presenc
alter
mental
statu
nonspecif
marker
infect
older
patient
necessarili
indic
nervou
system
infect
would
younger
adult
exampl
uniqu
symptom
infect
older
patient
includ
lethargi
tachypnea
loss
appetit
dehydr
weak
dizzi
fall
incontin
final
due
presenc
multipl
comorbid
condit
increas
incid
delirium
patient
popul
challeng
acquir
thorough
histori
present
ill
would
normal
assist
initi
diagnosi
infect
look
diseasespecif
diagnosi
sever
import
diagnost
consider
uniqu
older
adult
exampl
older
adult
bacteremia
may
present
typic
sign
fever
chill
older
adult
urinari
tract
infect
often
present
confus
less
like
younger
adult
present
classic
symptom
urinari
frequenc
pain
moreov
older
adult
pneumonia
like
present
gener
weak
fall
hypoxemia
rather
typic
symptom
fever
chest
pain
symptom
may
unreli
indic
infect
patient
biomark
erythrocyt
sediment
rate
crp
lactat
procalcitonin
still
play
import
diagnost
role
biomark
may
elev
baselin
due
increas
age
presenc
multipl
diseas
state
result
clinician
assess
biomark
rel
patient
previou
find
baselin
level
alert
extrem
elev
valu
clinician
anticip
potenti
issu
check
valu
may
difficult
obtain
adequ
laboratori
test
cultur
patient
frail
cognit
declin
sepsi
syndrom
inflammatori
respons
infect
typic
diagnos
use
system
inflammatori
respons
syndrom
sir
criteria
typic
sign
sepsi
sir
criteria
commonli
seen
geriatr
patient
one
notabl
exampl
difficulti
assess
sir
criteria
temperatur
c
underli
problem
assess
temperatur
older
adult
fact
bodi
baselin
temperatur
chang
age
often
time
c
lower
older
adult
younger
adult
addit
decreas
temperatur
respons
infect
result
decreas
cytokin
product
decreas
sensit
hypothalamu
cytokin
poor
peripher
thermoregul
malnutrit
also
lead
decreas
temperatur
respons
infect
result
factor
older
adult
may
blunt
effect
temperatur
respons
infect
mean
patient
infect
could
less
like
younger
adult
present
typic
sign
fever
still
import
assess
temperatur
patient
may
provid
import
clinic
inform
fact
one
studi
found
addit
shake
chill
elev
temperatur
good
predictor
bacteremia
patient
age
year
old
addit
may
advantag
assess
chang
temperatur
individu
patient
baselin
rather
absolut
temperatur
valu
older
adult
patient
mani
common
comorbid
older
adult
may
also
increas
risk
infect
common
comorbid
link
increas
risk
infect
congest
heart
failur
chronic
kidney
diseas
diabet
mellitu
chronic
liver
failur
chronic
obstruct
lung
diseas
malign
chronic
infect
chronic
diabet
mellitu
increas
infect
risk
due
format
neuropathi
poor
vasculatur
longstand
histori
diseas
also
lead
delay
phagocytosi
correspond
decreas
clearanc
yeast
bacteria
neutrophil
chronic
kidney
diseas
also
thought
caus
similar
impair
immun
system
diabet
mellitu
iron
overload
inhibit
cellular
immun
effector
function
commonli
seen
chronic
kidney
diseas
due
potenti
supplement
iron
treatment
anemia
chronic
diseas
chronic
liver
failur
caus
impair
complement
factor
format
prolifer
cellular
immun
older
adult
like
multipl
comorbid
increas
risk
infect
comorbid
may
also
mask
delay
sepsi
diagnosi
serum
lactat
level
consid
use
biomark
diagnosi
sepsi
lactat
develop
occur
anaerob
metabol
caus
hypoperfus
end
organ
lactat
level
increas
mortal
risk
due
sepsi
comorbid
anemia
sever
dehydr
increas
lactat
level
due
lack
red
blood
cell
fluid
mani
older
adult
may
anemia
like
remain
adequ
hydrat
may
risk
increas
serum
lactat
level
howev
still
recommend
obtain
lactat
level
set
sepsi
may
caus
pneumonia
delay
time
achiev
clinic
stabil
evalu
use
pharmacotherapi
first
import
consid
number
chang
seen
absorpt
distribut
metabol
elimin
drug
older
adult
absorpt
medic
may
declin
older
adult
atrophi
gastric
pariet
cell
increas
gastric
ph
may
alter
absorpt
medic
depend
gastric
acid
delay
empti
time
lead
decreas
rate
absorpt
decreas
drug
peak
concentr
anoth
problem
older
adult
patient
decreas
intestin
surfac
area
decreas
abdomin
blood
flow
may
limit
system
drug
absorpt
older
adult
tend
alter
bodi
composit
lean
muscl
mass
decreas
bodi
fat
increas
total
bodi
water
also
decreas
estim
patient
age
year
old
lead
decreas
percentag
total
bodi
water
increas
concentr
adipos
tissu
lead
decreas
volum
distribut
hydrophil
medic
increas
volum
distribut
lipophil
medic
older
adult
also
decreas
serum
albumin
lead
increas
concentr
free
fraction
drug
normal
highli
protein
bound
import
chang
way
older
adult
metabol
elimin
medic
agerel
declin
hepat
blood
flow
impair
hepat
enzym
lead
decreas
firstpass
effect
increas
halfliv
hepat
clear
medic
renal
function
difficult
estim
older
patient
due
agerel
decreas
muscl
mass
also
agerel
damag
glomeruli
decreas
renal
filtrat
capac
lead
decreas
clearanc
electrolyt
renal
clear
medic
import
consid
age
influenc
typic
pharmacokineticpharmacodynam
profil
antimicrobi
agent
older
adult
avoid
use
standard
adult
dose
nomogram
pharmacokinet
chang
ultim
variabl
implic
treatment
sepsi
must
weigh
heavili
initi
therapi
instanc
older
adult
tend
decreas
system
perfus
result
atherosclerosi
increas
peripher
vascular
resist
effect
may
increas
case
sepsi
ultim
medic
decreas
penetr
tissu
contribut
subtherapeut
concentr
drug
lead
higher
incid
treatment
failur
altern
due
decreas
perfus
liver
kidney
metabol
elimin
antimicrobi
may
decreas
lead
increas
risk
variou
toxic
older
adult
multipl
comorbid
suscept
polypharmaci
may
pose
addit
risk
adr
initi
resuscit
septic
patient
achiev
within
hour
triag
use
protocolbas
process
protocolbas
resuscit
associ
improv
mortal
outcom
older
adult
place
emphasi
earli
aggress
administr
adequ
intraven
iv
fluid
strategi
serv
optim
cardiac
preload
improv
preserv
organ
perfus
pressur
hemodynam
target
met
patient
initi
receiv
mlkg
iv
fluid
challeng
follow
addit
fluid
therapi
patient
longer
demonstr
hemodynam
improv
though
patient
like
greater
risk
underresuscit
caution
taken
avoid
excess
resuscit
particularli
patient
known
heart
failur
signific
renal
impair
administr
vasoact
agent
recommend
improv
preserv
sepsisinduc
endorgan
perfus
patient
septic
shock
exhibit
lifethreaten
hypotens
mean
arteri
pressur
map
drive
pressur
peripher
blood
flow
serv
therapeut
target
patient
sepsisinduc
endorgan
hypoperfus
ssc
guidelin
provid
strong
recommend
revers
hypotens
patient
septic
shock
character
arteri
hypotens
despit
adequ
fluid
resuscit
vasopressor
target
initi
goal
map
mm
hg
higher
goal
may
benefici
patient
hypertens
atherosclerosi
common
comorbid
older
patient
one
studi
demonstr
target
map
mm
hg
result
improv
renal
function
compar
standard
target
patient
histori
arteri
hypertens
howev
differ
mortal
seen
patient
high
target
group
greater
incid
atrial
fibril
individu
assess
region
global
perfus
lactat
concentr
mental
statu
urin
output
also
import
monitor
treatment
target
vasoact
agent
broadli
differenti
vasopressor
inotrop
vasodil
agent
commonli
sever
properti
larg
effect
establish
minim
accept
map
maintain
organ
perfus
receptor
pharmacolog
vasoact
agent
ultim
determin
physiolog
properti
impact
variou
hemodynam
paramet
term
import
benefici
advers
effect
select
specif
agent
larg
guid
balanc
benefici
hemodynam
effect
unwant
advers
effect
safeti
concern
may
amplifi
older
adult
particularli
multipl
comorbid
diseas
state
ssc
guidelin
support
norepinephrin
ne
prefer
vasopressor
particularli
hypovolemia
yet
resolv
iv
fluid
administr
ongo
howev
choic
vasopressor
septic
shock
remain
matter
debat
even
latest
guidelin
public
vasopressor
work
primarili
augment
system
vascular
resist
agent
also
increas
cardiac
output
co
exampl
ne
potent
adrenerg
agonist
dopamin
da
alphaand
betaadrenerg
activ
well
differ
degre
ne
addit
activ
dopaminerg
receptor
alphaadrenerg
mechan
improv
map
increas
vascular
tone
may
decreas
co
region
blood
flow
cutan
splanchnic
renal
tissu
betaadrenerg
mechan
maintain
blood
flow
inotrop
chronotrop
effect
increas
splanchnic
perfus
howev
also
unwant
consequ
tachycardia
increas
cellular
metabol
immunosuppress
effect
tachycardia
affect
myocardium
reduc
myocardi
oxygen
perfus
increas
myocardi
oxygen
demand
previou
studi
high
heart
rate
associ
increas
mortal
septic
shock
similar
sever
clinic
trial
compar
ne
da
patient
septic
shock
compar
ne
da
demonstr
higher
rel
risk
shortterm
mortal
tachycardia
new
diagnosi
arrhythmia
base
trial
routin
use
da
support
recommend
altern
vasopressor
agent
ne
select
patient
low
risk
tachyarrhythmia
absolut
rel
bradycardia
da
agent
administ
peripher
access
reason
option
earli
care
patient
yet
establish
central
line
access
use
da
low
dose
dopaminerg
effect
impact
patient
outcom
use
role
discourag
epinephrin
recommend
altern
vasopressor
ad
potenti
substitut
ne
addit
agent
need
maintain
adequ
blood
pressur
epinephrin
potent
effect
alphaand
betaadrenerg
receptor
ne
da
also
stimul
receptor
ad
effect
may
deleteri
impact
lactat
clearanc
splanchnic
circul
though
translat
wors
outcom
clinic
studi
studi
compar
epinephrin
ne
found
differ
mortal
advers
effect
includ
tachycardia
arrhythmia
phenylephrin
pure
alphaadrenerg
agonist
pose
risk
tachycardia
due
potent
vasoconstrictor
effect
high
probabl
decreas
stroke
volum
place
agent
lastlin
vasopressor
treatment
septic
shock
phenylephrin
recommend
except
case
neassoci
arrhythmia
high
co
state
salvag
therapi
vasopressor
agent
fail
vasopressin
adjunct
catecholamin
patient
sever
septic
shock
base
rel
vasopressin
defici
hypothesi
endogen
vasopressin
level
rel
lower
anticip
major
patient
hour
shock
continu
administ
exogen
vasopressin
restor
vascular
tone
blood
pressur
therebi
reduc
need
catecholamin
vasopressin
replac
therapi
increas
overal
blood
pressur
unclear
effect
blood
flow
local
area
heart
kidney
intestin
higher
dose
vasopressin
unitsmin
associ
cardiac
arrest
digit
splanchnic
ischemia
addit
unitsmin
vasopressin
ne
result
differ
mortal
compar
ne
alon
patient
septic
shock
howev
vasopressin
demonstr
mortal
benefit
catecholaminespar
effect
patient
less
sever
shock
current
ssc
guidelin
recommend
vasopressin
unitsmin
addon
therapi
ne
achiev
target
map
decreas
ne
dosag
requir
vasopressin
monotherapi
recommend
higher
dose
avoid
maintain
high
co
sepsi
gener
associ
better
outcom
one
import
target
egdt
howev
use
inotrop
drug
boost
co
oxygen
deliveri
establish
septic
shock
shown
lead
increas
mortal
rate
septic
shock
patient
remain
hypotens
adequ
iv
fluid
resuscit
may
low
normal
increas
co
result
treatment
combin
inotrop
vasopressor
ne
epinephrin
recommend
co
measur
co
measur
vasopressor
ne
may
use
separ
target
specif
level
map
co
first
choic
inotrop
patient
measur
suspect
low
co
presenc
adequ
fluid
resuscit
map
dobutamin
ssc
guidelin
recommend
trial
dobutamin
situat
myocardi
dysfunct
ongo
tissu
hypoperfus
despit
adequ
intravascular
volum
map
use
strategi
increas
cardiac
index
predetermin
supranorm
level
found
benefici
avoid
recent
main
focu
clinic
trial
sinc
last
ssc
guidelin
updat
evalu
use
egdt
provid
fluid
resuscit
septic
patient
main
use
vasopressor
addit
iv
fluid
achiev
map
mm
hg
mani
controversi
addit
vasopressor
includ
type
vasopressor
achiev
map
goal
question
remain
target
higher
map
goal
mm
hg
may
benefici
older
adult
due
addit
comorbid
clinic
trial
ssc
support
goal
elev
although
mani
clinic
trial
includ
older
adult
popul
subgroup
analys
specif
recommend
clinician
extrapol
older
adult
fluid
resuscit
time
ssc
guidelin
strongli
recommend
appropri
broadspectrum
antibiot
regimen
administ
within
one
hour
recognit
sever
sepsi
septic
shock
previous
mention
time
recognit
sepsi
challeng
older
patient
patient
atyp
symptom
gener
declin
health
statu
inabl
perform
activ
daili
live
chang
mental
statu
incontin
like
increas
mortal
rate
sepsi
order
improv
recognit
sepsi
time
administr
antibiot
patient
atyp
symptom
evalu
possibl
sepsi
treat
aggress
proper
select
dose
antimicrobi
regimen
also
critic
inappropri
empir
therapi
independ
predictor
mortal
particularli
older
adult
antimicrobi
regimen
includ
one
agent
activ
like
pathogen
sever
factor
taken
consider
select
agent
includ
suspect
site
infect
comorbid
antibiot
exposur
past
day
nurs
home
resid
avail
patient
prior
cultur
result
facilityspecif
antibacteri
surveil
data
also
help
older
adult
approxim
time
like
gramneg
pathogen
compar
younger
age
group
multidrug
resist
organ
methicillinresist
staphylococcu
aureu
vancomycinresist
enterococci
extendedspectrum
beta
lactamaseproduc
organ
also
like
identifi
resid
longterm
care
facil
base
site
infect
older
adult
slight
differ
pathogen
requir
broad
spectrum
antibiot
tabl
broadspectrum
antibiot
start
initi
deescal
appropri
antibiot
alway
start
full
initi
dose
adjust
base
renal
function
regimen
select
import
monitor
potenti
advers
drug
reaction
adr
older
adult
adr
occur
time
often
popul
especi
import
note
patient
sepsi
antimicrobi
shown
among
common
therapeut
class
associ
adr
geriatr
popul
exampl
aminoglycosid
ie
tobramycin
shown
increas
incid
ototox
older
adult
howev
may
part
due
inappropri
dose
patient
tend
impair
baselin
renal
function
fluoroquinolon
anoth
class
pose
particular
risk
older
adult
patient
tend
longer
qt
interv
make
higher
risk
danger
fluoroquinoloneinduc
qt
prolong
sourc
control
also
import
septic
older
adult
guidelin
advoc
rapid
identif
infect
sourc
control
intervent
within
hour
common
infect
site
older
adult
sever
sepsi
includ
lung
urinari
tract
abdomen
sourc
control
procedur
includ
remov
cathet
drainag
abscess
debrid
necrot
tissu
remov
empyema
conserv
manag
approach
address
sourc
control
avoid
patient
sever
sepsi
regardless
age
requir
consider
number
support
care
intervent
ventil
patient
receiv
protocolbas
sedat
daili
interrupt
assess
spontan
breath
trial
toler
older
adult
high
risk
icu
delirium
particularli
problemat
underli
dementia
prevent
strategi
paramount
includ
routin
delirium
assess
adequ
pain
control
prevent
constip
avoid
deliriogen
medic
benzodiazepin
anticholinerg
agent
patient
receiv
venou
thromboembol
prophylaxi
low
molecular
weightor
unfraction
heparin
unless
contraind
stress
ulcer
prophylaxi
proton
pump
inhibitor
receptor
blocker
patient
receiv
protocolbas
glucos
manag
target
blood
glucos
mgdl
avoid
hypoglycemia
enter
nutrit
initi
first
hour
care
feasibl
particularli
import
older
adult
may
adequ
nutrit
statu
prior
admiss
set
goal
care
end
life
plan
import
concept
septic
older
adult
area
often
overlook
ssc
guidelin
provid
recommend
regard
goal
care
paramount
sepsi
patient
especi
import
older
adult
popul
goal
care
prognosi
discuss
patient
famili
incorpor
treatment
end
life
care
plan
discuss
soon
feasibl
later
hour
icu
admiss
discuss
end
life
plan
focu
two
key
concept
ethic
decis
make
share
decis
make
four
ethic
principl
autonomi
selfdetermin
benefic
good
nonmalefic
harm
justic
equal
treatment
equal
access
treatment
addit
mani
believ
verac
also
includ
one
exercis
autonomi
without
told
need
make
inform
decis
share
decis
make
approach
allow
patient
famili
clinician
share
care
process
understand
everyon
desir
comfort
approach
share
decis
make
continuum
allow
balanc
two
concept
long
commun
judgment
parti
optim
order
achiev
sever
variabl
must
taken
account
share
everyon
involv
patient
care
includ
full
understand
patient
medic
condit
prognosi
futur
qualiti
life
organ
care
attitud
medic
staff
cultur
religi
belief
elevenyear
review
sever
sepsi
trend
unit
state
show
dramat
increas
rate
hospit
fatal
popul
year
age
time
especi
compar
year
age
due
increas
sever
mortal
associ
sepsi
older
adult
reason
consid
limit
aggress
treatment
cours
icu
limit
withdraw
care
may
patient
best
interest
may
legal
right
full
involv
patient
famili
treatment
process
progress
room
improv
implement
strategi
integr
everyon
involv
patient
care
round
process
provid
daili
review
treatment
care
plan
earli
involv
palli
care
servic
diagnos
manag
sepsi
older
adult
challeng
due
atyp
symptom
present
temperatur
respons
blunt
delay
older
adult
due
poor
peripher
thermal
regul
decreas
cytokin
product
clinician
identifi
shake
chill
elev
temperatur
physic
exam
good
predictor
bacteremia
older
adult
although
specif
temperatur
recommend
older
adult
clinician
continu
assess
chang
patient
baselin
instead
reli
design
absolut
temperatur
valu
older
adult
multipl
factor
includ
immunosenesc
agerel
chang
includ
skin
breakdown
decreas
cough
reflex
increas
risk
infect
recommend
provid
treatment
older
adult
sepsi
older
adult
requir
fluid
resuscit
due
septic
shock
import
provid
fluid
challeng
mlkg
iv
follow
continu
fluid
therapi
howev
import
avoid
excess
resuscit
may
caus
addit
harm
older
adult
heart
failur
signific
renal
impair
older
adult
exhibit
lifethreaten
hypotens
addit
vasoact
agent
recommend
achiev
map
mm
hg
maintain
perfus
studi
suggest
target
higher
map
mm
hg
patient
atherosclerosi
hypertens
howev
none
studi
demonstr
chang
overal
mortal
appropri
broad
spectrum
antibiot
cover
gramposit
gramneg
organ
initi
within
first
hour
sepsi
diagnosi
sinc
older
adult
increas
risk
contract
pseudomona
aeruginosa
methicillinresist
staphylococcu
aureu
pathogen
resist
narrowspectrum
antibiot
common
antibiot
use
treatment
sepsi
ie
vancomycin
piperacillintazobactam
meropenem
tobramycin
requir
dosag
adjust
due
renal
insuffici
may
increas
risk
potenti
advers
drug
reaction
ie
nephrotox
ototox
seizur
etc
adult
popul
continu
age
older
adult
popul
risk
infect
continu
increas
lack
studi
clinic
trial
evalu
treatment
older
adult
sepsi
need
addit
studi
evalu
special
popul
commonli
affect
sepsi
includ
older
adult
conclus
sepsi
timedepend
syndrom
late
diagnosi
lead
increas
mortal
risk
diagnos
treat
appropri
older
adult
contract
sepsi
greater
mortal
risk
due
delay
time
diagnosi
area
need
addit
research
special
popul
well
recognit
specif
guidelin
within
futur
updat
societi
critic
care
medicin
ssc
guidelin
aforement
recommend
clinician
abl
appli
recommend
identifi
diagnos
sepsi
older
adult
present
atyp
symptom
provid
appropri
treatment
optim
outcom
immunosenes
addit
comorbid
includ
diabet
chronic
kidney
diseas
inflammag
lead
increas
risk
infect
older
adult
sepsi
difficult
diagnos
older
adult
tend
present
atyp
symptom
lack
classic
sir
criteria
especi
temperatur
c
drug
select
challeng
patient
popul
due
multipl
pharmacokinet
pharmacodynam
chang
relat
age
older
adult
increas
risk
contract
drugresist
pathogen
addit
gramneg
bacteria
therefor
broadspectrum
antibiot
dose
appropri
initi
dose
may
need
adjust
dose
base
renal
function
especi
older
adult
vasopressor
may
need
order
help
achiev
appropri
map
level
howev
appropri
map
level
older
adult
specifi
appropri
vasopressor
older
adult
identifi
fluid
resuscit
need
patient
hypotens
sepsi
diagnosi
achiev
map
mm
hg
older
adult
higher
risk
develop
icu
delirium
clinician
need
perform
routin
delirium
assess
adequ
pain
control
prevent
constip
avoid
benzodiazepin
anticholinerg
agent
deliriogen
medic
mortal
increas
delay
sepsi
diagnosi
clinician
discuss
goal
care
prognosi
patient
famili
incorpor
goal
treatment
end
life
care
plan
discuss
feasibl
later
hour
icu
admiss
